ICON PUBLIC LIMITED

ICLR
Delayed Quote. Delayed  - 02/26 04:00:00 pm
180.68USD -2.04%
Upcoming events on ICON PUBLIC LIMITED COMPANY
04/28/21 Q1 2021 Earnings Release (Projected)
07/28/21 Interim 2021 Earnings Release (Projected)
10/27/21 Q3 2021 Earnings Release (Projected)
02/23/22 FY 2021 Earnings Release (Projected)

Past events on ICON PUBLIC LIMITED COMPANY
02/25/21 | 09:00amFY 2020 Earnings Call
02/24/21 | 04:15pmFY 2020 Earnings Release
01/12/21 | 07:30amJP Morgan Healthcare Conference
12/16/20NASH US Summit

Upcoming sector events for ICON PUBLIC LIMITED COMPANY
02/26/21 | 04:35pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

Past sector events for ICON PUBLIC LIMITED COMPANY
02/25/21 | 01:40pmGILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 | 01:40pmEXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20192020 (e)
Sales
M $
Released
Forecast
Spread
2 806
2 814
-0,29%

2 788
Operating income
(EBITDA)
M $
Released
Forecast
Spread
495
494
0,18%

471
Operating profit
(EBIT)
M $
Released
Forecast
Spread
433
433
0,15%

403
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
427
426
0,20%

378
Net income
M $
Released
Forecast
Spread
374
374
-0,07%

330
EPS
$
Released
Forecast
Spread
6,79
6,89
-1,4%

6,17
Announcement Date02/19/2020


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
702
661
6,1%

750
Operating income
(EBITDA)
M $
Released
Forecast
Spread
125
111
13%

130
Operating profit
(EBIT)
M $
Released
Forecast
Spread
108
95,0
14%

114
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
105
92,1
14%

111
Net income
M $
Released
Forecast
Spread
91,6
81,9
12%

97,3
EPS
$
Released
Forecast
Spread
1,72
1,54
12%

1,83
Announcement Date10/21/2020

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise